An In Vitro—In Vivo Simulation Approach for the Prediction of Bioequivalence
The aim of this study was to develop a new in vitro—in vivo simulation (IVIVS) approach in order to predict the outcome of a bioequivalence study. The predictability of the IVIVS procedure was evaluated through its application in the development process of a new generic product of amlodipine/irbesar...
Main Authors: | Marilena Vlachou, Vangelis Karalis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Materials |
Subjects: | |
Online Access: | https://www.mdpi.com/1996-1944/14/3/555 |
Similar Items
-
In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria
by: C.O. Esimone, et al.
Published: (2008-02-01) -
In Vitro– In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone
by: Elena M. Tosca, et al.
Published: (2021-02-01) -
Bioequivalence of Oral Drug Products in the Healthy and Special Populations: Assessment and Prediction Using a Newly Developed In Vitro System “BE Checker”
by: Takato Masada, et al.
Published: (2021-07-01) -
In Vitro Dissolution and in Silico Modeling Shortcuts in Bioequivalence Testing
by: Moawia M. Al-Tabakha, et al.
Published: (2020-01-01) -
In Vivo Predictive Dissolution (IPD) for Carbamazepine Formulations: Additional Evidence Regarding a Biopredictive Dissolution Medium
by: Marival Bermejo, et al.
Published: (2020-06-01)